Niki BioSolutions,

Niki BioSolutions, Dividend Coverage

Dividend Coverage Ratio of Niki BioSolutions, (NIKI) as of Oct 20, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Niki BioSolutions, is 2026 - . Dividend Coverage Ratio of Niki BioSolutions, was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Niki BioSolutions, Stock analysis

What does Niki BioSolutions, do? Niki BioSolutions, Inc. is a clinical-stage biopharmaceutical company based in Princeton, US, focused on developing therapeutic products for oncology and infectious diseases. The company operates through a pipeline including SACT-1 (Phase 1 for neuroblastoma), ALS-4 (Phase 1 for bacterial infections), and preclinical candidates like SACT-COV19 and ALS-1 targeting coronavirus and MRSA. It was formerly Aptorum Group Limited, rebranding in July 2026 following its listing on 17 July 2026. Niki BioSolutions, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Niki BioSolutions, stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Niki BioSolutions, since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Niki BioSolutions, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — Niki BioSolutions,

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — Niki BioSolutions,